ArticleFrontiers in parasitology2023

Chagas disease treatment efficacy markers: experiences from a Phase III study with nifurtimox in children.

Ulrike Grossmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.